Jobs

Part-time considered (minimum 22.5 hours per week)


Salary range £35k-£45k pro rata


One Nucleus, the Cambridge headquartered membership organisation for life science companies is now recruiting for a Member Engagement Manager to work within the Business Development team to deliver member support, events and sector reports.


Role:


Working as part of the team to meet the collective Business Development goals including to :

Isomerase is an innovative, growing biotechnology company based at Chesterford Research Park near Cambridge, UK. It was founded in 2012 and has particular expertise in synthetic biology, bioengineering and the discovery and development of the next generation of microbial natural products, proteins and peptides for use in areas such as medicine, agritech or sustainable alternatives to existing petroleum based products.

We are looking for excellent candidates able to work in a multidisciplinary team generating technologies and solving problems on the chemistry/biology interface.

We are looking for two driven individuals to join us as Lead Manufacturing Biotechnologists.


We are RoslinCT, a world-leading cell and gene therapy contract development and manufacturing organisation creating cutting-edge therapies that change people’s lives. Collaborative, dedicated and talented people are at the backbone of our culture, working both autonomously and in driven teams to make life-changing products utilising ground-breaking science.

A BIT ABOUT US…

At F-star, we are dedicated to developing next generation immunotherapies to transform the lives of patients with cancer. We develop mAb², a novel class of disruptive bispecific antibody-based therapies that have the potential to overcome tumour resistance and restore anti-cancer immunity and responsiveness.

We are committed to delivering life-changing treatments for the estimated 80% of patients with cancer who currently fail to have a durable response to immunotherapies.

A BIT ABOUT US…

At F-star, we are dedicated to developing next generation immunotherapies to transform the lives of patients with cancer. We develop mAb², a novel class of disruptive bispecific antibody-based therapies that have the potential to overcome tumor resistance and restore anti-cancer immunity and responsiveness.

We are committed to delivering life-changing treatments for the estimated 80% of patients with cancer who currently fail to have a durable response to immunotherapies.

Biocrucible is developing a class-leading molecular diagnostic platform based on its proprietary isothermal nucleic acid amplification technology. This platform has the potential to offer rapid results with PCR-like levels of sensitivity and specificity but in a fully-disposable format usable by both consumers at home and also in low-resource environments. The acquisition by Sapphiros in July 2021 has provided further investment and operational support to accelerate this next-generation platform to market.

Frequasense Limited was set up in 2020 with the intention of bringing a point of care medical device for the rapid detection of sepsis using its own proprietary technology to market over the next 2-3 years. The team has built on experimental testing, knowledge and development gathered over the last 10 years. The CEO has successfully won grants totalling over £1M over this time period as well as securing 2 rounds of investment. Individuals in the team have also collectively invested their own funds worth £150K.

A BIT ABOUT US…

At F-star, we are dedicated to developing next generation immunotherapies to transform the lives of patients with cancer. We develop mAb², a novel class of disruptive bispecific antibody-based therapies that have the potential to overcome tumour resistance and restore anti-cancer immunity and responsiveness.

We have an exciting opportunity for an Associate Director / Director, Project Management to join our Development team, reporting into the VP, Project and Portfolio Management. We’re looking for an individual with significant experience in project/strategical management of clinical projects including budget forecasting and active tracking. You will ideally have worked within biologics drug development, if not, a solid understanding of biologic/pharmaceutical drug development is essential.

Pages